Literature DB >> 20441416

Alemtuzumab: the future of chronic inflammatory demyelinating polyradiculoneuropathy treatment?

Thomas H Brannagan, Shanna K Patterson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20441416     DOI: 10.1586/eci.10.23

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


× No keyword cloud information.
  3 in total

Review 1.  Treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  Inna Kleyman; Thomas H Brannagan
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

Review 2.  Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside.

Authors:  Amanda C Peltier; Peter D Donofrio
Journal:  Semin Neurol       Date:  2012-11-01       Impact factor: 3.420

3.  A case of chronic inflammatory demyelinating polyneuropathy presented with unilateral ptosis.

Authors:  Sadegh Izadi; Sina Karamimagham; Maryam Poursadeghfard
Journal:  Med J Islam Repub Iran       Date:  2014-05-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.